{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000393","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2024-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.286202+00:00","generated_at":"2026-06-06T20:08:19.989891+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"CNS Pharmaceuticals to appoint Amy Mahery as independent director upon financing close","bullets":["Amy Mahery appointed as independent Board member effective upon completion of Company's financing.","She will not serve on any Board committees initially.","Compensation will follow standard non-employee director program as previously disclosed.","No other changes to Board or management."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000393","json":"https://secwatch.observer/filing/0001683168-24-000393.json","markdown":"https://secwatch.observer/filing/0001683168-24-000393.md","text":"https://secwatch.observer/filing/0001683168-24-000393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/0001683168-24-000393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/cns_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:08:19.989891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a82a11446","claim":"Amy Mahery was appointed as Director at CNS Pharmaceuticals, Inc..","evidence_excerpt":"On January 17, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) agreed to appoint Amy Mahery as an independent member of the Company’s Board of Directors effective upon the completion of the Company’s financing.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/0001683168-24-000393-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}